Developing Potential Candidates of Preclinical Preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Proteomics
• Genetics

Background:

• Identifying early biomarkers for preeclampsia is crucial for timely intervention.
• Limited access to first-trimester trophoblast and decidual tissues hinders the study of candidate genes.
• Investigating secreted proteins detectable in maternal circulation is key for early detection.

Purpose of the Study:

• To investigate whether candidate genes identified through microarray analysis encode secreted proteins detectable in early pregnancy.
• To evaluate the utility of various proteomic methods for detecting these candidate proteins in first-trimester samples.
• To explore the potential for developing a protein-based screening panel for preeclampsia.

Main Methods:

• Pilot studies using mass spectrometry-based proteomic assays.
• Enzyme-linked immunosorbent assays (ELISAs) and Western immunoblotting on first-trimester samples.
• Development of targeted mass spectrometry methods, including multiple reaction monitoring (MRM) assays.

Main Results:

• Several candidate proteins were detected in early gestation samples.
• Targeted mass spectrometry yielded robust MRM assays for protein quantification.
• Despite successful detection, challenges in early pregnancy biomarker discovery persist.

Conclusions:

• Proteomic analysis of first-trimester samples can detect potential preeclampsia biomarkers.
• Novel targeted mass spectrometry methods show promise for sensitive protein detection.
• Future antibody-based studies and multiplex panels are needed for effective preeclampsia screening and mitigation.